These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16410530

  • 1. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
    Iikuni N, Okamoto H, Yoshio T, Sato E, Kamitsuji S, Iwamoto T, Momohara S, Taniguchi A, Yamanaka H, Minota S, Kamatani N.
    Ann Rheum Dis; 2006 Feb; 65(2):253-6. PubMed ID: 16410530
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
    Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Llorente L, Sánchez-Guerrero J.
    Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
    [Abstract] [Full Text] [Related]

  • 3. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
    Yoshio T, Hirata D, Onda K, Nara H, Minota S.
    J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
    [Abstract] [Full Text] [Related]

  • 4. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 5. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

  • 6. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
    Yoshio T, Okamoto H, Kurasawa K, Dei Y, Hirohata S, Minota S.
    Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
    [Abstract] [Full Text] [Related]

  • 7. Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus.
    Ikenouchi-Sugita A, Yoshimura R, Okamoto T, Umene-Nakano W, Ueda N, Hori H, Katsuki A, Saito K, Tanaka Y, Nakamura J.
    World J Biol Psychiatry; 2010 Mar; 11(2):121-8. PubMed ID: 20109107
    [Abstract] [Full Text] [Related]

  • 8. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P.
    Scand J Rheumatol; 2007 Mar; 36(6):442-7. PubMed ID: 18092265
    [Abstract] [Full Text] [Related]

  • 9. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Núñez-Alvarez CA, Llorente L, Sánchez-Guerrero J.
    J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
    [Abstract] [Full Text] [Related]

  • 10. [Expression of monocyte chemoattractant protein-1 and lupus nephritis].
    Liu ZJ, Lin JY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):491-5. PubMed ID: 16178446
    [Abstract] [Full Text] [Related]

  • 11. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
    Lu XY, Ye S, Wang Y, Guo L, Chen XX, Fan W, Wang XD, Gu YY, Bao CD, Liu Q.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2462-6. PubMed ID: 17156673
    [Abstract] [Full Text] [Related]

  • 12. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes.
    Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, Grimm A, Devore MD, Wingrove C, Zhang L.
    Arthritis Rheum; 2008 Nov 15; 59(11):1639-46. PubMed ID: 18975359
    [Abstract] [Full Text] [Related]

  • 13. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sánchez-Guerrero J.
    PLoS One; 2008 Oct 06; 3(10):e3347. PubMed ID: 18836530
    [Abstract] [Full Text] [Related]

  • 14. MCP-1 in the cerebrospinal fluid of children with acute lymphoblastic leukemia.
    Eisenkraft A, Keidan I, Bielorai B, Keller N, Toren A, Paret G.
    Leuk Res; 2006 Oct 06; 30(10):1259-61. PubMed ID: 16516290
    [Abstract] [Full Text] [Related]

  • 15. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging.
    Bosma GP, Rood MJ, Zwinderman AH, Huizinga TW, van Buchem MA.
    Arthritis Rheum; 2000 Jan 06; 43(1):48-54. PubMed ID: 10643699
    [Abstract] [Full Text] [Related]

  • 16. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
    Fragoso-Loyo H, Atisha-Fregoso Y, Nuñez-Alvarez CA, Llorente L.
    Lupus; 2016 Apr 06; 25(4):364-9. PubMed ID: 26466614
    [Abstract] [Full Text] [Related]

  • 17. Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations.
    Vogelgesang SA, Heyes MP, West SG, Salazar AM, Sfikakis PP, Lipnick RN, Klipple GL, Tsokos GC.
    J Rheumatol; 1996 May 06; 23(5):850-5. PubMed ID: 8724297
    [Abstract] [Full Text] [Related]

  • 18. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S, Arinuma Y, Takayama M, Yoshio T.
    Arthritis Res Ther; 2007 May 06; 9(3):R44. PubMed ID: 17472755
    [Abstract] [Full Text] [Related]

  • 19. Concentration of interferon-inducible T cell chemoattractant and monocyte chemotactic protein-1 in serum and cerebrospinal fluid of patients with Lyme borreliosis.
    Grygorczuk S, Zajkowska J, Swierzbińska R, Pancewicz S, Kondrusik M, Hermanowska-Szpakowicz T.
    Rocz Akad Med Bialymst; 2005 May 06; 50():173-8. PubMed ID: 16358960
    [Abstract] [Full Text] [Related]

  • 20. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
    Arinuma Y, Yanagida T, Hirohata S.
    Arthritis Rheum; 2008 Apr 06; 58(4):1130-5. PubMed ID: 18383393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.